CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 130 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243 | -99.7% | 16,328 | -17.3% | 0.02% | +300.0% |
| Q1 2021 | $90,000 | +9.8% | 19,745 | +38.3% | 0.01% | -33.3% |
| Q4 2020 | $82,000 | -82.0% | 14,276 | -77.4% | 0.01% | -88.5% |
| Q3 2020 | $456,000 | +590.9% | 63,051 | +87.6% | 0.08% | +1200.0% |
| Q4 2019 | $66,000 | -61.6% | 33,607 | +40.1% | 0.01% | -40.0% |
| Q2 2019 | $172,000 | -21.5% | 23,992 | +21.3% | 0.01% | -23.1% |
| Q3 2018 | $219,000 | -3.9% | 19,787 | -20.0% | 0.01% | +8.3% |
| Q4 2017 | $228,000 | +78.1% | 24,735 | +56.2% | 0.01% | +100.0% |
| Q3 2017 | $128,000 | – | 15,836 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |